Modulation of prion protein expression through cryptic splice site manipulation.
Journal article
Gentile JE. et al, (2023), bioRxiv
Systematic identification of disease-causing promoter and untranslated region variants in 8,040 undiagnosed individuals with rare disease.
Journal article
Martin-Geary AC. et al, (2023), medRxiv
Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
Journal article
Allouba M. et al, (2023), Eur Heart J
Exome-wide evidence of compound heterozygous effects across common phenotypes in the UK Biobank
Preprint
Lassen FH. et al, (2023)
Not all exons are protein coding: Addressing a common misconception
Journal article
Aspden JL. et al, (2023), Cell Genomics, 3, 100296 - 100296
2022 Curt Stern Award introduction: Heidi Rehm.
Journal article
Whiffin N., (2023), Am J Hum Genet, 110
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant.
Journal article
Hoorntje ET. et al, (2022), Circulation. Genomic and precision medicine
Recommendations for clinical interpretation of variants found in non-coding regions of the genome.
Journal article
Ellingford JM. et al, (2022), Genome medicine, 14
Genetic constraint at single amino acid resolution improves missense variant prioritisation and gene discovery
Preprint
Zhang X. et al, (2022)
MRSD: A quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease.
Journal article
Rowlands CF. et al, (2022), American journal of human genetics, 109, 210 - 222
Author Correction: Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes (Nature Communications, (2020), 11, 1, (2539), 10.1038/s41467-019-12438-5)
Journal article
Wang Q. et al, (2021), Nature Communications, 12
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes.
Journal article
Cubuk C. et al, (2021), Genetics in medicine : official journal of the American College of Medical Genetics, 23, 2096 - 2104
New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy.
Journal article
Aguib Y. et al, (2021), Circulation, 144, 754 - 757
Non-coding region variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms.
Journal article
Wright CF. et al, (2021), American journal of human genetics, 108, 1083 - 1094
Quantitative evidence evaluation for singleton rare missense variants in rare distinctive adult-onset phenotypes: the exemplar of SDHB and SDHD
Conference paper
King L. et al, (2021), MOLECULAR GENETICS AND METABOLISM, 132, S37 - S37
Author Correction: Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals.
Journal article
Whiffin N. et al, (2021), Nature communications, 12
Author Correction: The effect of LRRK2 loss-of-function variants in humans.
Journal article
Whiffin N. et al, (2021), Nature medicine, 27
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.
Journal article
Tadros R. et al, (2021), Nature genetics, 53, 128 - 134
Author Correction: A structural variation reference for medical and population genetics (Nature, (2020), 581, 7809, (444-451), 10.1038/s41586-020-2287-8)
Journal article
Collins RL. et al, (2021), Nature
Author Correction: Evaluating drug targets through human loss-of-function genetic variation (Nature, (2020), 581, 7809, (459-464), 10.1038/s41586-020-2267-z)
Journal article
Minikel EV. et al, (2021), Nature